CureVac
CVAC
CVAC was delisted on the 5th of January, 2026.
112 hedge funds and large institutions have $750M invested in CureVac in 2021 Q3 according to their latest regulatory filings, with 32 funds opening new positions, 36 increasing their positions, 30 reducing their positions, and 28 closing their positions.
20% more repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 30
14% more first-time investments, than exits
New positions opened: 32 | Existing positions closed: 28
3% more funds holding
Funds holding: 109 → 112 (+3)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.08% less ownership
Funds ownership: 7.43% → 7.35% (-0.08%)
26% less capital invested
Capital invested by funds: $1.02B → $750M (-$269M)
46% less call options, than puts
Call options by funds: $70M | Put options by funds: $129M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$28.9M |
| 2 |
Millennium Management
New York
|
+$14M |
| 3 |
Group One Trading
Chicago,
Illinois
|
+$13M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$8.16M |
| 5 |
Voloridge Investment Management
Jupiter,
Florida
|
+$6.47M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
-$94.9M |
| 2 |
DZ Bank
Frankfurt Am Main,
Germany
|
-$6.8M |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$6.63M |
| 4 |
Korea Investment Corp
Seoul,
South Korea
|
-$3.73M |
| 5 |
California State Teachers Retirement System (CalSTRS)
West Sacramento,
California
|
-$2.78M |
CVAC Hedge Fund Activity: Q3 2021 in Review
112 institutional investors reported a position in CureVac (CVAC) for Q3 2021, worth a combined $750M — down 26% from $1.02B a quarter earlier.
Buyers outnumbered sellers: 32 funds opened new CVAC positions and 28 closed out — a net gain of 4 holders — while 36 added to existing stakes and 30 trimmed.
The largest buyer was T. Rowe Price Associates, adding an estimated $28.9M. The largest seller was Baillie Gifford & Co, cutting an estimated $94.9M.
- 112 institutional investors held CureVac (CVAC) as of Q3 2021, up from 109 in Q2 2021.
- Funds reported $750M of CureVac stock for Q3 2021, down 26% quarter-over-quarter.
- 32 funds opened new CureVac positions in Q3 2021 and 28 closed out, a net change of +4 holders.
- The largest CureVac buyer in Q3 2021 was T. Rowe Price Associates, an estimated $28.9M added.
- The largest CureVac seller in Q3 2021 was Baillie Gifford & Co, an estimated $94.9M sold.
Based on aggregated 13F filings for Q3 2021.